Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase

NCT05592379 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT05592379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase
Lead sponsor
University of Wisconsin, Madison
Phase
Phase 1
Overall status
Completed
Start date
November 7, 2023
Completion date
February 19, 2025
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, psychedelic experiences, sleep